KATA PENGANTAR

Puji dan syukur ke hadirat Allah swt, karena atas rahmat dan kurnia-Nya, penulisan
paper Epilepsi dapat diselesaikan. Paper ini diajukan untuk melengkapi tugas pada
Kepaniteraan Klinik Senior Departemen ilmu penyakit Saraf, Fakultas Kedokteran,
Universitas Islam Sumatera Utara di RSUD Dr. Pirngadi Medan.

Meskipun penulisan paper ini banyak mengalami hambatan, kesulitan dan kendala,
namun karena adanya bimbingan, petunjuk, nasihat dan motivasi dari berbagai pihak,
penulisan paper ini dapat diselesaikan. Di sini kami mengucapkan terima kasih kepada dr.
Kolman Saragih, Sp.S atas bimbingannya.

Akhir kata, meskipun berbagai usaha telah dilakukan semaksimal mungkin dalam
menyelesaikan penulisan paper ini, namun karena keterbatasan pengalaman, pengetahuan,
kepustakaan dan waktu, paper ini masih jauh dari kesempurnaan. Untuk ini, kritik dan saran
dari berbagai pihak sangat diharapkan untuk menyempurnakan paper ini.

Medan, Maret 2017

Penulis

i
 DAFTAR ISI

Kata Pengantar ........................................................................................................................ i

Daftar Isi ................................................................................................................................. ii

Daftar Gambar ........................................................................................................................ iii

BAB I PENDAHULUAN

1.1 Latar belakang ................................................................................................................... 1

BAB II TINJAUAN PUSTAKA

2.1 Definisi .......................................................................................................................... 2

2.2 Epidemiologi ................................................................................................................... 2
2.3 Etiologi ............................................................................................................................ 3
2.4 Patofisiologi ..................................................................................................................... 5
2.5 Klasifikasi .......................................................................................................................... 7
2.6 Gejala klinis .................................................................................................................... 8
2.7 Manifestasi Klinis ..........................................................................................................10
2.8 Diagnosis ........................................................................................................................ 14
2.9 Diagnosa Banding ............................................................................................................18
2.10 Penatalaksanaan .............................................................................................................19
2.11 Komplikasi .................................................................................................................22
2.12 Pencegahan .................................................................................................................22
2.13 Prognosis ......................................................................................................................22

BAB III KESIMPULAN .....................................................................................................23

BAB IV LAPORAN KASUS ............................................................................................... 24

DAFTAR PUSTAKA .......................................................................................................31

ii
 DAFTAR GAMBAR

1. Patofisiologi Epilepsi ...................................................................................................... 6

2. Fase Tonik Klonik.......................................................................................................... 9

3. Mekanisme Kerja Obat Anti Epilepsi ............................................................................. 20

iii